ANI Pharmaceuticals (ANIP)
ANI Pharmaceuticals (ANIP) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- ANIP last traded at $68.55 on 2026-11-20, -0.84% for the session.
- ANI Pharmaceuticals: market cap $1.56B, P/E 13.8, revenue $1.04B over the last four quarters.
- Over the past year ANIP returned -14.66%, with a year-to-date return of -13.16%.
ANIP Slips as Investors Weigh Egetis Deal
ANI Pharmaceuticals is down 1.8% today while the S&P 500 and Nasdaq 100 are higher. The company announced another investor conference, but attention may remain on its proposed Egetis acquisition and the financing and first-year earnings dilution tied to the deal.
Published 2026-11-19 15:01:13 UTC.